Pharmacological therapy of pericardial diseases

Current Pharmaceutical Design

Volumn 21, Issue 4, 2015, Pages 525-530

  Imazio, Massimo ^a   Adler, Yehuda ^b  

^a MARIA VITTORIA HOSPITAL   (Italy)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Cardiac tamponade; Constrictive pericarditis; Pericardial effusion; Pericarditis; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; COLCHICINE; CORTICOSTEROID; ETHAMBUTOL; IBUPROFEN; INDOMETACIN; ISONIAZID; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CHEMOTHERAPY; CONSTRICTIVE PERICARDITIS; HEART TAMPONADE; HUMAN; HYPERTENSION; PERICARDIAL DISEASE; PERICARDIAL EFFUSION; PERICARDIECTOMY; PERICARDITIS; PRIORITY JOURNAL; TUBERCULOUS PERICARDITIS;

HUMANS; PERICARDITIS;

EID: 84925844086     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161282104141204144622     Document Type: Article

References (43)

1. [1] Lilly LS. Treatment of acute and recurrent idiopathic pericarditis. Circulation 2013; 127(16): 1723-6.
2. [2] Imazio M, Brucato A, Mayosi BM, et al. Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditis. J Cardiovasc Med (Hagerstown) 2010; 11(10): 712-22.
3. [3] Imazio M, Brucato A, Mayosi BM, et al. Medical therapy of pericardial diseases: part II: Noninfectious pericarditis, pericardial effusion and constrictive pericarditis. J Cardiovasc Med (Hagerstown) 2010 Nov; 11(11): 785-94.
4. [4] Imazio M, Cecchi E, Demichelis B, et al. Indicators of Poor Prognosis of Acute Pericarditis. Circulation 2007; 115: 2739-2744.
5. [5] Permanyer-Miralda G, Sagristá-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol 1985; 56: 623-630.
6. [6] Zayas R, Anguita M, Torres F, et al. Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis. Am J Cardiol 1995; 75: 378-82.
7. [7] Lange RA, Hillis LD. Acute pericarditis. N Engl J Med 2004; 351: 2195-202.
8. [8] Maisch B, Seferovic PM, Ristic AD, et al. Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the Diagnosis and Management of Pericardial Diseases. Eur Heart J 2004; 25: 587-610.
9. [9] Reuter H, Burgess LJ, Doubell AF. Epidemiology of pericardial effusions at a large academic hospital in South Africa. Epidemiol Infect 2005; 133: 393-9.
10. [10] Imazio M, Brucato A, Derosa FG, et al. Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med (Hagerstown) 2009; 10: 217-30.
11. [11] Lotrionte M, Biondi-Zoccai G, Imazio M, et al. International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am Heart J 2010; 160(4): 662-70.
12. [12] Imazio M, Brucato A, Trinchero R, Spodick D, Adler Y. Individualized therapy for pericarditis. Expert Rev Cardiovasc Ther 2009; 7(8): 965-75.
13. [13] Imazio M, Brucato A, Maestroni S, et al. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation 2011; 123(10): 1092-7.
14. [14] Imazio M, Brucato A, Rampello S, et al. Management of pericardial diseases during pregnancy. J Cardiovasc Med(Hagerstown) 2010; 11(8): 557-62.
15. [15] Imazio M. Pericardial involvement in systemic inflammatory diseases. Heart 2011; 97(22): 1882-92.
16. [16] Imazio M. Contemporary management of pericardial diseases. Curr Opin Cardiol 2012; 27(3): 308-17.
17. [17] Imazio M, Brucato A, Cumetti D, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation 2008; 118(6): 667-71.
18. [18] Imazio M, Brucato A, Cemin R, et al. CORP (COlchicine for Recurrent Pericarditis) Investigators. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med 2011; 155(7): 409-14.
19. [19] Imazio M, Brucato A, Forno D, et al. Efficacy and safety of colchicine for pericarditis prevention. Systematic review and metaanalysis. Heart 2012; 98(14): 1078-82.
20. [20] Imazio M. Treatment of recurrent pericarditis. Expert Rev Cardiovasc Ther 2012; 10(9): 1165-72.
21. [21] Vianello F, Cinetto F, Cavraro M, et al. Azathioprine in isolated recurrent pericarditis: a single centre experience. Int J Cardiol 2011; 147(3): 477-8.
22. [22] Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation 2005; 112(23): 3608-16.
23. [23] Syed FF, Mayosi BM. A modern approach to tuberculous pericarditis. Prog Cardiovasc Dis 2007; 50(3): 218-36.
24. [24] Lestuzzi C, Bearz A, Imazio M., et al. Neoplastic pericardial disease in lung cancer: impact on outcomes of different treatment strategies. A multicenter study. Lung Cancer 2011; 72(3): 340-7.
25. [25] Burazor I, Imazio M, Markel G, Adler Y. Malignant pericardial effusion. Cardiology 2013; 124(4): 224-32.
26. [26] Shabetai R. Pericardial effusion: haemodynamic spectrum. Heart 2004; 90: 255-6.
27. [27] Shabetai R. Function of the normal pericardium. Clin Cardiol 1999; 22(1 Suppl 1): I4-5.
28. [28] Soler-Soler J, Sagristà-Sauleda J, Permanyer-Miralda G. Management of pericardial effusion. Heart 2001; 86: 235-40.
29. [29] Spodick DH. Acute cardiac tamponade. N Engl J Med 2003; 349: 684-90.
30. [30] Imazio M, Mayosi BM, Brucato A, et al. Triage and management of pericardial effusion. J Cardiovasc Med (Hagerstown) 2010; 11: 928-35.
31. [31] Sagristà-Sauleda J, Mercé AS, Soler-Soler J. Diagnosis and management of pericardial effusion. World J Cardiol 2011; 3: 135-43.
32. [32] Corey GR, Campbell PT, Van Trigt, et al. Etiology of large pericardial effusions. Am J Med 1993; 95: 209-13.
33. [33] Sagrista-Sauleda J, Merce J, Permanyer-Miralda G, Soler-Soler J. Clinical clues to the causes of large pericardial effusions. Am J Med 2000; 109: 95-101.
34. [34] Levy PY, Corey R, Berger P, et al. Etiologic diagnosis of 204 pericardial effusions. Medicine (Baltimore) 2003; 82: 385-91.
35. [35] Ma W, Liu J, Zeng Y, et al. Causes of moderate to large pericardial effusion requiring pericardiocentesis in 140 Han Chinese patients. Herz 2012; 37: 183-7.
36. [36] Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J 2013; 34(16): 1186-97.
37. [37] Ling LH, Oh JK, Schaff HV, et al. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation 1999; 100: 1380-6.
38. [38] Bertog SC, Thambidorai SK, Parakh K, et al. Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol 2004; 43: 1445-2.
39. [39] Talreja DR, Edwards WD, Danielson GK, et al. Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation 2003; 108: 1852-7.
40. [40] Sagrista-Sauleda J, Permanyer-Miralda G, Candell-Riera J, Angel J, Soler-Soler J. Transient cardiac constriction: an unrecognized pattern of evolution in effusive acute idiopathic pericarditis. Am J Cardiol 1987; 59: 961-6.
41. [41] Haley JH, Tajik AJ, Danielson GK, Schaff HV, Mulvagh SL, Oh JK. Transient constrictive pericarditis: causes and natural history. J Am Coll Cardiol 2004; 43: 271-5.
42. [42] Sagrista-Sauleda J, Angel J, Sanchez A, Permanyer-Miralda G, Soler-Soler J. Effusive-constrictive pericarditis. N Engl J Med 2004; 350: 469-75.
43. [43] Feng D, Glockner J, Kim K, et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study. Circulation 2011; 124(17): 1830-7.